Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test the safety and efficacy of an experimental drug, OMP-305B83, when given in combination with FOLFIRI or FOLFOX. OMP-305B83 is a humanized bispecific monoclonal anti...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
OncoMed Pharmaceuticals, Inc.
NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more
NCT07536113 · Metastatic Colorectal Cancer (CRC)
NCT07416552 · Metastatic Colorectal Cancer
NCT07228832 · Metastatic Colorectal Cancer (CRC)
NCT06625775 · Solid Tumor, Adult, Metastatic Breast Cancer, and more
City of Hope National Medical Center
Duarte, California
Rocky Mountain Cancer Centers
Denver, Colorado
Cancer Care & Hematology - Fort Collins
Fort Collins, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions